Previous works showed that MFN2 expression is reduced in patients with obesity or type 2 diabetes as well as in obese Zucker rats, a model of type 2 diabetes, suggesting that mitochondrial fusion is an important factor in the pathophysiology of these disorders [59, 60]. This evidence concerns the gene MFN2 and obesity disorder.